Cogent Biosciences, Inc. (COGT): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$7.87M
Year ended 2020-12-31
-2.0%
3-year compound annual growth
$22.50M2017-12-31: $8.36M2018-12-31: $9.73M2019-12-31: $22.50M2020-12-31: $7.87M$7.87M
2017-12-31 Revenue (USD) 2020-12-31
Period endedRevenueChange YoYSource filing
2020-12-31$7.87M-65.0%2022-03-15, From 2020-01-01
2019-12-31$22.50M+131.1%2021-03-16, From 2019-01-01
2018-12-31$9.73M+16.4%2020-03-26, From 2018-01-01
2017-12-31$8.36Mn/a2019-03-28, From 2017-01-01